Desmoid Tumor Active Not Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: Desmoid-Type Fibromatosis / Desmoid Type-fibromatosis / Aggressive Fibromatosis / Desmoid tumour / Fibromatosis, Aggressive / Desmoid Tumors / Fibromatosis Desmoid / Desmoid Fibromatosis / Aggressive fibromatosis (disorder) / Aggressive fibromatosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0028471 (Desmoid Tumor)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02834013Nivolumab and Ipilimumab in Treating Patients With Rare TumorsTreatment